Lexicon Pharmaceuticals
LXRX
#7546
Rank
NZ$0.47 B
Marketcap
$1.32
Share price
-4.42%
Change (1 day)
-26.20%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.16. In 2022 the company made an earnings per share (EPS) of -$1.04 an increase over its 2021 EPS that were of -$1.04.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.116.87%
2022-$1.04-0%
2021-$1.0410.91%
2020-$0.94-145.08%
2019$2.08-206.09%
2018-$1.96-5.74%
2017-$2.08-10.95%
2016-$2.342640%
2015-$0.08531-96.34%
2014-$2.33-2.53%
2013-$2.39-9.09%
2012-$2.63-37.14%
2011-$4.180%
2010-$4.18-39.66%
2009-$6.933.57%
2008-$6.69-8.2%
2007-$7.29-24.69%
2006-$9.6742.11%
2005-$6.81-22.97%
2004-$8.84-35.09%
2003-$13.61-0%
2002-$13.6162.86%
2001-$8.36-19.54%
2000-$10.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.62 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.74-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.47 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.33-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.17-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.81 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$45.40 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.68-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.28 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA